Acceptance of a Telemedical Intervention in Patients with COPD
- Conditions
- chronic obstructive pulmonary disease (COPD)J44Other chronic obstructive pulmonary disease
- Registration Number
- DRKS00000239
- Lead Sponsor
- Robert Bosch Healthcare GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 43
1. written consent
2. male or female ambulatory treated patients
3. patients with COPD - GOLD classification III and IV
4. patients with COPD - GOLD classification I and II -, with an inpatient treatment of COPD lasting not longer than 3 months
5. patient has blood pressure when resting not higher than 180/100 mmHg
6. patient has the cognitive ability and intention to use the Health Buddy® with its peripherals
7. patient has adequate knowledge of the German language
8. patient has an active telephone connection, preferably analogue
9. patient is motivated to take part in the trial
1. patient is currently participating in another trial or finished participation within the previous 4 weeks
2. patient is pregnant or breastfeeding
3. patient currently has known malignant or virulent illnesses
4. patient has a severe restriction of movements (e.g. paresis after stroke)
5. patient is invasively ventilated
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The patient´s compliance with the system as the primary outcome is measured by:<br>1. share of patients, who used the system more than two thirds of the available working days;<br>2. ratio of completely answered daily dialogues;<br>3. drop-out rate (percentage of patients who not continue to participate in the study until the final visit)
- Secondary Outcome Measures
Name Time Method 1. perceived security (SeCu-16)<br>2. patient´s acceptance of the programme<br>3. programme induced effort for healthcare professionals<br>4. healthcare professional´s acceptance of the therapy programme <br>5. number of acute exacerbations<br>6. health-related quality of life (SGRQ)<br>7. smoking status<br>8. number and type of hospitalisations<br>9. urgent visits